| Bioactivity | RYTVELA is a deriviative of the peptide antagonist of interleukin-1 receptor 1 (IL-1R1) d-(RYTVELA) (HY-P10353) that contains all L-amino acids[1]. |
| CAS | 1200829-06-6 |
| Sequence | Arg-Tyr-Thr-Val-Glu-Leu-Ala |
| Shortening | RYTVELA |
| Formula | C38H62N10O12 |
| Molar Mass | 850.96 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Christiane Quiniou, et al. Interleukin-1 and ischemic brain injury in the newborn: Development of a small molecule inhibitor of IL-1 receptor. Semin. Semin Perinatol. 2008 Oct;32(5):325-33. |
RYTVELA
CAS: 1200829-06-6 F: C38H62N10O12 W: 850.96
RYTVELA is a deriviative of the peptide antagonist of interleukin-1 receptor 1 (IL-1R1) d-(RYTVELA) (HY-P10353) that con
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.